Issue: April 2013
February 26, 2013
3 min read
Save

Obesity linked to risk for molecular subtype of colorectal cancer

Issue: April 2013
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Evidence has suggested that metabolic diseases such as obesity and type 2 diabetes are affected by a genetic and functional variation in the WNT/beta-catenin, or CTNNB1 signaling pathway. In a recent study, researchers suggest that obesity and physical inactivity are associated with risk for a molecular subtype of colorectal cancer.

“We know that exercise and avoiding obesity decrease colorectal cancer risk, but little is known about why,” researcher Shuji Ogino, MD, PhD, associate professor of pathology at Dana-Farber Cancer Institute and associate professor of epidemiology at Harvard School of Public Health, said in a press release. “In this study, we used a biomarker named CTNNB1, which is a molecule implicated in cancer and obesity, to divide patients into two groups, CTNNB1-positive and CTNNB1-negative.”

Shuji Ogino, MD, PhD 

Shuji Ogino

In their clinical follow-up of 109,046 women in the Nurses’ Health Study and 47,684 men in the Health Professional’s Follow-up Study, the researchers discovered 861 incidents of rectal and colon cancers with tissue immunohistochemistry data on the nuclear biomarker, CTNNB1 expression, they wrote.

According to data, greater BMI was linked to a significantly higher risk for CTNNB1-negative cancer (multivariate HR=1.34; 95% CI, 0.92-1.25 for 5 kg/m2 increment), but not with CTNNB1-positive cancer risk (multivariate HR=1.07; 95% CI, 0.92-1.25 for 5 kg/m2 increment, between CTNNB1-negative and CTNNB1-positive risks), they wrote.

Moreover, physical activity levels were related to a lower risk for CTNNB1-negative cancer (multivariate HR=0.93; 95% CI, 0.87-1 for 10 MET-hours per week increment), but not with CTNNB1-positive cancer risk (multivariate HR=0.98; 95% CI, 0.91-1.05 for 10 MET-hours per week increment).

“Our results provide additional evidence for a causal role of obesity and a physically inactive lifestyle in a specific molecular subtype of colorectal cancer,” Ogino said in the release. “If physicians are able to identify individuals who are prone to develop CTNNB1-negative cancer, then it would be possible to strongly recommend physical activity.”

Therefore, the researchers suggest energy balance and metabolism status employed the effect in a specific carcinogenesis pathway which is less likely dependent on WNT/CTNNB1 activation. These findings hold potential for developing improved cancer prevention strategies, they wrote.

Disclosure: The researchers report no relevant financial disclosures.